Lack of association between serum myonectin levels and sarcopenia in older Asian adults
暂无分享,去创建一个
Beom-Jun Kim | H. Yoo | Kyungeun Kim | J. Baek | H. Jung | So Jeong Park | Jin-Young Lee | Sunghwan Ji | Il-Young Jang
[1] Beom-Jun Kim,et al. Serum irisin level is independent of sarcopenia and related muscle parameters in older adults , 2022, Experimental Gerontology.
[2] A. Picca,et al. Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis , 2021, Ageing Research Reviews.
[3] C. Celis-Morales,et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis , 2021, Journal of cachexia, sarcopenia and muscle.
[4] R. Ramírez‐Vélez,et al. Heart failure-related skeletal myopathy. Potential involvement of myokines. , 2021, Revista espanola de cardiologia.
[5] K. Higuchi,et al. Pathophysiology and mechanisms of primary sarcopenia (Review). , 2021, International journal of molecular medicine.
[6] M. Chang,et al. Prevalence of Sarcopenia Among the Elderly in Korea: A Meta-Analysis , 2021, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[7] Beom-Jun Kim,et al. Association between serum FGF21 level and sarcopenia in older adults. , 2021, Bone.
[8] Sooyeon Oh,et al. Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma , 2020, Clinical and molecular hepatology.
[9] Mina Wang,et al. Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments , 2020, Frontiers in Endocrinology.
[10] Q. Xiao,et al. Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets? , 2020, Experimental Gerontology.
[11] Lei Li,et al. Serum myonectin is increased after laparoscopic sleeve gastrectomy , 2020, Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.
[12] K. Park,et al. Associations between the quality of life in sarcopenia measured with the SarQoL® and nutritional status , 2020, Health and Quality of Life Outcomes.
[13] B. Pedersen,et al. Muscle–Organ Crosstalk: The Emerging Roles of Myokines , 2020, Endocrine reviews.
[14] J. Chang,et al. Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes , 2020, Pflügers Archiv - European Journal of Physiology.
[15] L. Peng,et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.
[16] Z. Graham,et al. Myokines in skeletal muscle physiology and metabolism: Recent advances and future perspectives , 2020, Acta physiologica.
[17] Hee-Won Jung,et al. Characteristics of sarcopenia by European consensuses and a phenotype score , 2019, Journal of cachexia, sarcopenia and muscle.
[18] C. Battaglini,et al. Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review. , 2019, The oncologist.
[19] J. Guralnik,et al. Validation of a Multi–Sensor‐Based Kiosk for Short Physical Performance Battery , 2019, Journal of the American Geriatrics Society.
[20] A. Sayer,et al. Sarcopenia , 2019, The Lancet.
[21] A. Armani,et al. Fibroblast growth factor 21 controls mitophagy and muscle mass , 2019, Journal of cachexia, sarcopenia and muscle.
[22] H. Jun,et al. Role of Myokines in Regulating Skeletal Muscle Mass and Function , 2019, Front. Physiol..
[23] A. Rossi,et al. Sarcopenia and obesity , 2019, Current opinion in clinical nutrition and metabolic care.
[24] T. Murohara,et al. Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury , 2018, Circulation research.
[25] Hongting Zheng,et al. Circulating C1q/TNF‐related protein isoform 15 is a marker for the presence of metabolic syndrome , 2018, Diabetes/metabolism research and reviews.
[26] René Rizzoli,et al. Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.
[27] J. Reginster,et al. Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions , 2017, Aging Clinical and Experimental Research.
[28] Musarrat Maisha Reza,et al. Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy , 2017, Nature Communications.
[29] Y. Duan,et al. Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue. , 2017, Cytokine & growth factor reviews.
[30] P. Abete,et al. Biomarkers in sarcopenia: A multifactorial approach , 2016, Experimental Gerontology.
[31] James B. Brown,et al. Lessons from modENCODE. , 2015, Annual review of genomics and human genetics.
[32] W. Willett,et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older , 2015, Osteoporosis International.
[33] K. Casazza,et al. Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals , 2015, Journal of clinical & translational endocrinology.
[34] J. Peterson,et al. Effect of obesity and exercise on the expression of the novel myokines, Myonectin and Fibronectin type III domain containing 5 , 2014, PeerJ.
[35] C. Mantzoros,et al. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans , 2014, International Journal of Obesity.
[36] M. Deschenes,et al. The effects of sarcopenia on muscles with different recruitment patterns and myofiber profiles. , 2013, Current aging science.
[37] Jiandie D. Lin,et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. , 2013, Cell metabolism.
[38] M. Seldin,et al. Skeletal Muscle-derived Myonectin Activates the Mammalian Target of Rapamycin (mTOR) Pathway to Suppress Autophagy in Liver* , 2013, The Journal of Biological Chemistry.
[39] C. Cooper,et al. Quality of Life in Sarcopenia and Frailty , 2013, Calcified Tissue International.
[40] M. Sandri,et al. Cellular and molecular mechanisms of muscle atrophy , 2013, Disease Models & Mechanisms.
[41] M. Seldin,et al. Myonectin (CTRP15), a Novel Myokine That Links Skeletal Muscle to Systemic Lipid Homeostasis* , 2012, The Journal of Biological Chemistry.
[42] M. Malek,et al. Sarcopenia and diabetes: pathogenesis and consequences , 2011 .
[43] M. Drey. Sarcopenia – pathophysiology and clinical relevance , 2011, Wiener Medizinische Wochenschrift.
[44] M. Visser,et al. Consequences of sarcopenia. , 2011, Clinics in geriatric medicine.
[45] Avan Aihie Sayer,et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. , 2011, Age and ageing.
[46] J. E. Morley,et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives , 2008, The journal of nutrition, health & aging.
[47] D. Waitzberg,et al. Limitations and validation of bioelectrical impedance analysis in morbidly obese patients , 2005, Current opinion in clinical nutrition and metabolic care.
[48] Luigi Ferrucci,et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. , 2003, Journal of applied physiology.
[49] V. Hughes,et al. Sarcopenia: current concepts. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[50] S. Arver,et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] Gangyi Yang,et al. Myonectin Predicts the Development of Type 2 Diabetes , 2018, The Journal of clinical endocrinology and metabolism.
[52] Peel,et al. Gait Speed as a Measure in Geriatric Assessment in Clinical Settings : A , 2012 .
[53] Christine Neville,et al. The Watermemories Swimming Club: exercise and functional capacity outcomes for dementia , 2012 .
[54] K. Yarasheski,et al. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. , 2002, The journal of nutrition, health & aging.